{
    "medicine_id": "bfd977525695caa15cf9cdf000563817f7545e34",
    "platform_id": "DB06098",
    "metadata": {
        "name": "Cablivi 11 mg Kit Powder for solution",
        "composition": "11 mg PRLX 93936",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for use treatment in solid tumors",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "PRLX 93936 shows robust and selective toxicity in a wide variety of tumor cell lines and causes complete tumor regression in mouse xenograft models of fibrosarcoma pancreatic cancer ovarian cancer colon cancer and melanoma",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}